Barclays Wealth and Investment Management related stories
All articles and analysis
- Reuters - Shire To Buy SARcode Bioscience For $160M Plus Milestone Payouts
Shire is to buy privately owned U.S. biotech firm SARcode Bioscience, paying $160 million upfront to win rights to a new drug in late-stage development for dry eye diseases.
- Reuters - CDW Files for $500M IPO
Technology products retailer CDW Corp. filed with U.S. regulators to raise $500 million in an initial public offering, making it the latest private equity-backed company to file to go public this year. CDW was taken private in 2007 for $7.3 billion by Madison Dearborn Partners LLC and Providence Equity Partners. The proposed IPO could raise about $750 million, Reuters reported earlier this month.
- Reuters - Investcorp Struggling to Sell Armacell
Bahrain-based private equity firm Investcorp's sale of Armacell is under threat as bids for the German insulation firm are due to come in lower than its 500 million euro ($653.30 million) price tag, writes Reuters. The transaction could now be scrapped altogether, writes Reuters.
- Cinven and Warburg Pincus Plan to Further Reduce Ziggo Stake
Cinven and Warburg Pincus are planning to further reduce their stake in Ziggo. They intend to sell around 40 million ordinary shares in Ziggo N.V. via an accelerated bookbuild resulting in a stake of approximately 17.1 percent in the Dutch provider of entertainment, information and communication.
- Reuters - Pinnacle Foods Will Raise Up to $667M in I.P.O.
Packaged foods maker Pinnacle Foods Inc., backed by Blackstone Group LP, said it expects to raise as much as $667 million from its initial public offering, Reuters reported. The owner of the popular Bird Eye and Duncan Hines brands said in a regulatory filing with the U.S. Securities and Exchange Commission that it plans to sell 29 million shares at between $18 and $20 each. At the top end of the range, Pinnacle Foods would be valued at about $2.3 billion.